Impact of Mediterranean Diet Adherence in Early Pregnancy on Nausea, Vomiting, and Constipation
Metadatos
Mostrar el registro completo del ítemAutor
Barroso-Ruiz, Isabel; Cano Ibáñez, Naomi; Benito Villena, Rebeca; Martín Peláez, Sandra; Amezcua Prieto, María Del CarmenEditorial
Springer Nature
Materia
Pregnancy Nausea Vomiting
Fecha
2025-04-07Referencia bibliográfica
Barroso-Ruiz, I., Cano-Ibáñez, N., Benito-Villena, R. et al. Impact of Mediterranean Diet Adherence in Early Pregnancy on Nausea, Vomiting, and Constipation. Matern Child Health J 29, 639–649 (2025). [https://doi.org/10.1007/s10995-025-04078-7]
Patrocinador
Funding for open access publishing: Universidad de Granada/ CBUA; Funded (PI-0350-2018) by Fundación para la Investigación Biosanitaria de Andalucía Oriental (FIBAO - IBS).Resumen
Objectives Common maternal digestive symptoms, such as nausea, vomiting, and constipation during pregnancy, can impair pregnant women’s quality of life. The Mediterranean diet (MedDiet), characterized by a high consumption of olive oil, vegetables, fruits, legumes, and grains; moderate fish and dairy intake; and low meat consumption, could alleviate these symptoms. This study aims to study the prevalence of maternal digestive symptoms in the different pregnancy trimesters and to examine the association between baseline MedDiet adherence and the prevalence of maternal digestive symptoms during pregnancy. Methods A secondary analysis of the Walking Preg_Project trial was conducted in a cohort of adult Spanish pregnant women (N = 237) who provided data about MedDiet adherence and maternal digestive symptoms (nausea, vomiting, constipation) at baseline (12th ), 19th, and 32nd Gestational Week (GW). MedDiet adherence was appraised through a 13-item questionnaire and categorized into low, medium, and high adherence. Digestive symptoms were assessed by the Pregnancy Symptoms Inventory. The association between baseline MedDiet adherence and maternal digestive symptoms was evaluated through adjusted multinomial analysis. Results Differences among MedDiet adherence categories were considerable during pregnancy. Some of the greatest decreases were observed in high adherence to MedDiet in comparison with low MedDiet adherence at 32nd GW vs. 19th GW for the prevalence of nausea (10.0% vs. 18.8%, p < 0.001) and vomiting (5.0% vs. 8.7%, p < 0.001). Constipation remained during pregnancy. There was no significant association between the baseline MedDiet adherence and maternal gastrointestinal symptoms. Conclusion for Practice Baseline adherence to the MedDiet was not proven to influence nausea, vomiting, and constipation during pregnancy. For all MedDiet adherence groups, nausea and vomiting prevalence decreased throughout pregnancy, but not constipation.
Significance
Maternal gastrointestinal symptoms affect a large percentage of pregnant women during pregnancy. There are known different pharmaceutical measures against them, but very little is known about non-pharmaceutical ones. The MedDiet offers a broad range of food components that may collaborate to reduce gastrointestinal symptoms based on their physiology. Although the present study has not proven the influence of MedDiet on maternal gastrointestinal symptoms, the study adds a new line of research on this issue.